Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer

Predictive and prognostic biomarkers facilitate the selection of treatment strategies that can improve the survival of patients. Accumulating evidence indicates that long noncoding RNAs (lncRNAs) play important roles in cancer progression, with diagnostic and prognostic potential. However, few progn...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Chen, Zuyuan Yang, Chao Yang, Kan Xie, Weijun Sun, Shengli Xie
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Complexity
Online Access:http://dx.doi.org/10.1155/2018/1656273
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554536358641664
author Xin Chen
Zuyuan Yang
Chao Yang
Kan Xie
Weijun Sun
Shengli Xie
author_facet Xin Chen
Zuyuan Yang
Chao Yang
Kan Xie
Weijun Sun
Shengli Xie
author_sort Xin Chen
collection DOAJ
description Predictive and prognostic biomarkers facilitate the selection of treatment strategies that can improve the survival of patients. Accumulating evidence indicates that long noncoding RNAs (lncRNAs) play important roles in cancer progression, with diagnostic and prognostic potential. However, few prognostic lncRNAs are reported for breast cancer, and little is known about their functions that contribute to cancer pathogenesis. In this paper, we used weighted correlation network analysis (WGCNA) to construct networks containing noncoding and protein-coding genes based on their expression in 1097 breast cancer patients. The differentially expressed genes were significantly overlapped with gene modules regulating cell cycle and cell adhesion. The cell cycle-related lncRNAs were consistently downregulated in breast cancer. One lncRNA, EIF3J-AS1, is significantly associated with clinicopathological characteristics, including tumor size, lymph node metastasis, estrogen receptor (ER), and progesterone receptor (PR) status. Kaplan–Meier survival analysis revealed that EIF3J-AS1, a downregulated lncRNA in breast tumor, is a potential prognostic marker for breast cancer. EIF3J-AS1 may function in an estrogen-independent manner and could be inhibited by the compound FDI-6. Therefore, integrating sparse gene coexpression network and clinicopathological features can accelerate identification and functional characterization of novel prognostic lncRNAs in breast cancer.
format Article
id doaj-art-f1a89bea12f943fe95513e38a4676a28
institution Kabale University
issn 1076-2787
1099-0526
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Complexity
spelling doaj-art-f1a89bea12f943fe95513e38a4676a282025-02-03T05:51:22ZengWileyComplexity1076-27871099-05262018-01-01201810.1155/2018/16562731656273Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast CancerXin Chen0Zuyuan Yang1Chao Yang2Kan Xie3Weijun Sun4Shengli Xie5Guangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, ChinaGuangdong Key Laboratory of IoT Information Technology, School of Automation, Guangdong University of Technology, Guangzhou, Guangdong, ChinaPredictive and prognostic biomarkers facilitate the selection of treatment strategies that can improve the survival of patients. Accumulating evidence indicates that long noncoding RNAs (lncRNAs) play important roles in cancer progression, with diagnostic and prognostic potential. However, few prognostic lncRNAs are reported for breast cancer, and little is known about their functions that contribute to cancer pathogenesis. In this paper, we used weighted correlation network analysis (WGCNA) to construct networks containing noncoding and protein-coding genes based on their expression in 1097 breast cancer patients. The differentially expressed genes were significantly overlapped with gene modules regulating cell cycle and cell adhesion. The cell cycle-related lncRNAs were consistently downregulated in breast cancer. One lncRNA, EIF3J-AS1, is significantly associated with clinicopathological characteristics, including tumor size, lymph node metastasis, estrogen receptor (ER), and progesterone receptor (PR) status. Kaplan–Meier survival analysis revealed that EIF3J-AS1, a downregulated lncRNA in breast tumor, is a potential prognostic marker for breast cancer. EIF3J-AS1 may function in an estrogen-independent manner and could be inhibited by the compound FDI-6. Therefore, integrating sparse gene coexpression network and clinicopathological features can accelerate identification and functional characterization of novel prognostic lncRNAs in breast cancer.http://dx.doi.org/10.1155/2018/1656273
spellingShingle Xin Chen
Zuyuan Yang
Chao Yang
Kan Xie
Weijun Sun
Shengli Xie
Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
Complexity
title Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
title_full Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
title_fullStr Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
title_full_unstemmed Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
title_short Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer
title_sort sparse gene coexpression network analysis reveals eif3j as1 as a prognostic marker for breast cancer
url http://dx.doi.org/10.1155/2018/1656273
work_keys_str_mv AT xinchen sparsegenecoexpressionnetworkanalysisrevealseif3jas1asaprognosticmarkerforbreastcancer
AT zuyuanyang sparsegenecoexpressionnetworkanalysisrevealseif3jas1asaprognosticmarkerforbreastcancer
AT chaoyang sparsegenecoexpressionnetworkanalysisrevealseif3jas1asaprognosticmarkerforbreastcancer
AT kanxie sparsegenecoexpressionnetworkanalysisrevealseif3jas1asaprognosticmarkerforbreastcancer
AT weijunsun sparsegenecoexpressionnetworkanalysisrevealseif3jas1asaprognosticmarkerforbreastcancer
AT shenglixie sparsegenecoexpressionnetworkanalysisrevealseif3jas1asaprognosticmarkerforbreastcancer